This content is from: Premium
Pershing Square Discloses Zoetis Stake — and Sachem Head Pact
The two hedge fund firms have worked together in the past, including on Valeant Pharmaceutical’s pursuit of Allergan.
William Ackman, Pershing Square Capital Management (Bloomberg)When William Ackman’s Pershing Square Capital Management disclosed Tuesday that it had amassed an 8.5 percent activist stake in Zoetis, the animal health company, it also revealed that it had a joint filing agreement with hedge fund firm Sachem Head Capital Management, run by
To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.